Clinical Trial Update: Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating inhaled extra-fine hydrofluoroalkane-beclomethasone (QVAR) for premature infants with bronchopulmonary dysplasia; current st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• QVAR (beclomethasone dipropionate inhalation aerosol)

Snippet

Sponsor: Bnai Zion Medical Center | Conditions: Bronchopulmonary Dysplasia | Phase 2 | Status: UNKNOWN